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Abstract
Background: High-throughput profiling of DNA methylation status of CpG islands is crucial to understand the
epigenetic regulation of genes. The microarray-based Infinium methylation assay by Illumina is one platform for
low-cost high-throughput methylation profiling. Both Beta-value and M-value statistics have been used as metrics
to measure methylation levels. However, there are no detailed studies of their relations and their strengths and
limitations.
Results: We demonstrate that the relationship between the Beta-value and M-value methods is a Logit
transformation, and show that the Beta-value method has severe heteroscedasticity for highly methylated or
unmethylated CpG sites. In order to evaluate the performance of the Beta-value and M-value methods for
identifying differentially methylated CpG sites, we designed a methylation titration experiment. The evaluation
results show that the M-value method provides much better performance in terms of Detection Rate (DR) and
True Positive Rate (TPR) for both highly methylated and unmethylated CpG sites. Imposing a minimum threshold
of difference can improve the performance of the M-value method but not the Beta-value method. We also
provide guidance for how to select the threshold of methylation differences.
Conclusions: The Beta-value has a more intuitive biological interpretation, but the M-value is more statistically
valid for the differential analysis of methylation levels. Therefore, we recommend using the M-value method for
conducting differential methylation analysis and including the Beta-value statistics when reporting the results to
investigators.
Background
Methylation of cytosine bases in DNA CpG islands is an
important epigenetic regulation mechanism in the organ
development, aging and different disease statuses [1].
Hypermethylation of CpG islands located in the promo-
ter regions of tumor suppressor genes has been firmly
established as one of the most common mechanisms for
gene regulation in cancer [2,3]. Therefore, high-through-
put profiling of DNA methylation status of CpG islands
is crucial for forwarding our understanding of the influ-
ence of epigenomics [4-6]. Microarray-based Illumina
Infinium methylation assay has been recently used in
epigenomic studies [7-9] due to its high throughput,
good accuracy, small sample requirement and relatively
low cost [1].
To estimate the methylation status, the Illumina Infi-
nium assay utilizes a pair of probes (a methylated probe
and an unmethylated probe) to measure the intensities
of the methylated and unmethylated alleles at the inter-
rogated CpG site [10]. The methylation level is then
estimated based on the measured intensities of this pair
of probes. To date, two methods have been proposed to
measure the methylation level. The first one is called
Beta-value, ranging from 0 to 1, which has been widely
used to measure the percentage of methylation. This is
the method currently recommended by Illumina [11,12].
The second method is the log2 ratio of the intensities of
methylated probe versus unmethylated probe [13]. We
have referred to it as the M-value method because it has
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analysis. Since both methods have their own strengths
and limitations, understanding the performance charac-
teristics of both measures is very important in providing
the best methylation analysis. We found some studies
that optimized clustering methylation data using the
Beta-value [14] method; but a rigorous comparison of
the two methods has not been done. For this reason, we
designed a titration experiment to compare and evaluate
these two methods. In the following sections, we will
first define these two methods and derive the relation-
ship between them. Then we will evaluate the perfor-
mance of these two methods in detecting differentially
methylated CpG sites.
Results
Definition of Beta-value and M-value
The Beta-value is the ratio of the methylated probe
intensity and the overall intensity (sum of methylated
and unmethylated probe intensities). Following the nota-
tion used by Illumina methylation assay [12], Beta-value
for an i
th interrogated CpG site is defined as:
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where yi,menty and yi,unmenty are the intensities mea-
sured by the i
th methylated and unmethylated probes,
respectively. To avoid negative values after background
adjustment, any negative values will be reset to 0. Illu-
mina recommends adding a constant offset a (by
default, a = 100) to the denominator to regularize Beta
value when both methylated and unmethylated probe
intensities are low. The Beta-value statistic results in a
number between 0 and 1, or 0 and 100%. Under ideal
conditions, a value of zero indicates that all copies of
the CpG site in the sample were completely unmethy-
lated (no methylated molecules were measured) and a
value of one indicates that every copy of the site was
methylated. If we assume the probe intensities are
Gamma distributed, then the Beta-value follows a Beta
distribution. For this reason, it has been named the
Beta-value.
The M-value is calculated as the log2 ratio of the
intensities of methylated probe versus unmethylated
probe as shown in Equation 2:
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Here we slightly modified the definition given in [13]
by adding an offset a (by default, a = 1) to the intensity
values to prevent unexpected big changes due to small
intensity estimation errors, since for very small intensity
values (especially between 0 and 1), small changes of the
methylated and unmethylated probe intensities can
result in large changes in the M-value. A M-value close
to 0 indicates a similar intensity between the methylated
and unmethylated probes, which means the CpG site is
about half-methylated, assuming that the intensity data
has been properly normalized by Illumina GenomeStu-
dio or some other external normalization algorithm.
Positive M-values mean that more molecules are methy-
lated than unmethylated, while negative M-values mean
the opposite. The M-value has been widely used in
expression microarray analysis, especially two-color
microarray analysis. Therefore, many existing microarray
statistical frameworks using an M-value method can also
be applied to methylation data analysis.
Relationship between Beta-value and M-value
For Illumina methylation data, typically more than 95% of
interrogated CpG sites have intensities (yi,unmethy+yi,methy)
larger than 1000 (our evaluation dataset had 99.8% inter-
rogated CpG sites with intensities higher than 1000.).
Therefore, the relatively small offset value (i.e., 100) in the
denominator of Equation 1 has negligible effect on the
Beta-value for most interrogated CpG sites. Similarly,
the offset a in Equation 2 is also ignorable for most inter-
rogated CpG sites. Based on this observation, the relation-
ship between Beta-value and M-value can be derived by
substitution using Equation 1 and 2 (with the offset
ignored):
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Equation 3 indicates that the relationship is a logistic
function (shown as a base 2 logarithm instead of natural
logarithm). Figure 1 shows the relationship curve
between Beta and M-values. For example, Beta-values of
0.2, 0.5 and 0.8 correspond to M-values of -2, 0 and 2,
respectively. An approximately linear relationship can be
observed between Beta-value and M-value in the middle
range (from 0.2 to 0.8 for Beta-values and from -2 to 2
for M-values). As shown in Figure 1, Beta-values are
severely compressed at the extremes when compared
with M-values. As shown in the following sections, the
transformation of Beta-value into M-value provides a
straightforward method for using the Beta-value statistic
and obtaining the unique statistical properties of the
M-value.
Histograms of Beta-value and M-value
Figure 2 shows histograms of Beta-values and M-values
for a typical sample measured by the Illumina Infinium
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27,578 CpG sites in total, spread across promoter
regions of 14,495 genes. The range of Beta-values is
between 0 and 1, which can be interpreted as the
approximation of the percentage of methylation for the
population of a given CpG site in the sample. For
M-values, it is difficult to directly infer the degree of
methylation based on a single M-value, especially con-
sidering the range of M-values may change across differ-
ent datasets. The histogram of M-values clearly shows a
bimodal distribution, with one positive mode (methy-
lated mode) and one negative mode (unmethylated
mode). Conversely, because Beta-values are severely
compressed in the low (between 0 and 0.2) and high
(between 0.8 and 1) ranges compared with the M-value
statistic, its bimodal distribution is less obvious. There-
fore, the Beta-value has a direct correspondence with an
intuitive mental model of methylation (% methylation
for a given site) whereas the M-value may provide some
insight into the distribution of methylation across the
genome that is difficult to visualize with the Beta-value.
See the Conclusions section for additional discussion of
this point.
The distribution of standard deviation across different
methylation levels
In high-throughput statistical data analyses, many of
them, like canonical linearm o d e l so rA N O V A ,a s s u m e
t h ed a t ai shomoscedastic,i . e . ,t h ev a r i a b l ev a r i a n c e sa r e
approximately constant. The violation of this assump-
tion, which is described as heteroscedasticity in statistics,
imposes serious challenges when applying these analyses
to high-throughput data [15]. A common way to check
the homoscedasticity of the data is by visualizing the
relations between mean and standard deviation [15,16].
Figure 3 shows the mean and standard deviation rela-
tions of the Beta-value and M-value, which were calcu-
lated based on technical replicates. The red dots
represent the median standard deviation within a local
window. The data was first ranked by mean methylation
levels, and then binned into twenty non-overlapping
windows, with each bin containing 5% of the data. The
standard deviation of Beta-value is greatly compressed
in the low (between 0 and 0.2) and high (between 0.8
and 1) ranges. This means Beta-value has significant
heteroscedasticity in the low and high methylation
range. The problem of heteroscedasticity is effectively
resolved after transforming Beta-value to M-value using
Figure 1 The relationship curve between M-value and Beta-
value.
Figure 2 The histograms of Beta-value (left) and M-value (right) (27578 interrogated CpG sites in total).
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scedastic. Its standard deviation is approximately con-
stant across the entire methylation range for M-values.
The M-value statistic is therefore much more appropri-
ate for the homoscedastic assumptions of most statisti-
cal models used for microarray analysis. It should be
noted that other variance stabilization transformation
methods may also be used to transform the Beta-value
and stabilize the variance.
Performance comparison between Beta and M-values
Evaluation dataset
Titration data has been widely used to evaluate the
performance of new methods for analyzing mRNA
expression microarrays [16,17]. To apply this practice
to methylation analysis, we designed a methylation
titration experiment that enables the evaluation of the
performance of the Beta-value and M-value methyla-
tion analysis methods. Similar to the titration design
using Goldengate methylation chips by Bibikova and
et al. [12], we selected two samples known to contain
significant methylation differences. Sample A is a
B-lymphocyte sample from a male donor. Sample B is
a colon cancer sample from a female donor. The
sources of the methylation differences between sample
A and B include: (1) gender differences; (2) pathologi-
cal differences; (3) tissue differences. Samples A and B
were mixed at five different titration ratios: 100:0,
90:10, 75:25, 50:50 and 0:100. The mixed samples were
measured by Illumina Infinium HumanMethylation27
BeadChip with technical replicates. Please see the
Methods section for a more detailed description.
As shown in Figure 1, the middle range of logistic
transformation is approximately linear while the low
and high ranges have clear nonlinear relationships
between the Beta-value and M-value statistics. We have
grouped the results of the transformations into three
analysis groups, labeled as low, middle and high, with
the middle analysis group corresponding to the approxi-
mately linear range and the low and high groups in the
nonlinear range. This simplifies the analysis of the per-
formance of each statistic.
Beta-value: low (0, 0.2), middle [0.2, 0.8] and high
(0.8, 1).
M-value: low (-Inf, -2), middle [-2, 2] and high (2,
Inf).
Define differentially methylated CpG sites based on
correlation
If an examined CpG site has a significant methylation
difference between Sample A and B, its methylation pro-
file should be correlated with the titration profile shown
in Table 1. Therefore, wec a nu s et h ec o r r e l a t i o n
between the methylation and titration profile to validate
whether the CpG site is differentially methylated
between Sample A and B. Following similar criteria used
in the expression titration microarray experiments
[16,17], we claim a CpG site is differentially methylated
between Sample A and B if its absolute correlation coef-
ficients between titration and methylation profiles are
larger than 0.8 (correlation p-value is about 0.05) both
for Beta and M-value. There are 9845 investigated CpG
sites satisfying this criterion. We treat them as True
Positives (TP) to evaluate the performance of differential
methylation analysis.
Table 1 Design of the methylation titration experiment
% mix of A and B for each sample Mix1 Mix2 Mix3 Mix4 Mix5
A 100 90 75 50 0
B 0 1 02 55 01 0 0
Ntech* 22112
*N tech represents the number of technical replicates
Figure 3 The mean and standard deviation relations of technical replicates. Beta-value (left) and M-value (right).
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methylation analysis
One of the major statistical paradigms in expression
microarray analysis has been the “Fold change-ranking
with a non-stringent p-value cutoff” [18-20]. Under this
framework, the CpG islands will be first subject to a
low-stringency p-value threshold (p < 0.05 without the
correction of multiple comparisons); and then ranked by
fold changes. We hypothesized that M-value outper-
forms Beta-value under this statistical framework
because M-value is more homoscedastic and therefore
aligns better with the distribution assumptions of these
statistical methods.
Following a similar logical framework, we first used a
simple t-test to compare two technical replicates of
Sample A and two technical replicates of Sample B, and
require a differentially methylated CpG site to have
p-value < 0.05. We then separated these filtered CpG
sites into the three analysis groups listed in the “Evalua-
tion Dataset” subsection: low (2221 CpG sites for Beta-
value; 2794 CpG sites for M-value), middle (6855 CpG
sites for Beta-value; 6179 CpG sites for M-value) and
high (457 CpG sites for Beta-value; 625 CpG sites for
M-value) methylation analysis groups. In each analysis
group, we sorted the CpG sites in decreasing order
based on their absolute methylation difference between
Sample A and B, i.e.,     ,, Methylation Methylation Ai Bi − ,
where MethylationA i , represents the average methyla-
tion level of Sample A at i
th CpG site. We then evaluate
the performance of each method by selecting the top N
CpG sites as an evaluation set, with N starting at 50 and
incremented in steps of 50 until all sites were included
in the evaluation set. For each evaluation set (top N
CpG-sites), we calculated the True Positive Rate (TPR),
where TPR was defined as the percentage of identified
differentially methylated CpG sites being included in
the True Positives (TP) set, i.e., TPR =| TP∩CpGdetected|/
|CpGdetected|, where CpGdetected represents the CpG sites
included in the evaluation set. We also calculated the
Detection Rate (DR) for each evaluation set, where DR
was defined as the percentage of detected TP CpG sites
among all TP CpG sites, i.e., DR =| TP∩CpGdetected|/
|TP|. Figure 4 shows the performance curves of Beta
and M-value based on the relationship of 1 - DR versus
TPR. The definition of these curves is similar with the
ROC (Receiver Operating Characteristic) curve. In an
ideal situation, the best performance point is located at
the left top corner in the figure, where both DR and
TPR are equal to 1. Comparing the performance curve
of Beta and M-value, we can see that the M-value statis-
tic performs much better than Beta-value in the low and
high methylation range. In the middle range, their per-
formance is similar although the Beta-value has slightly
higher DR while the M-value has better TPR.
Refinement of the basic differential methylation analysis
Similar to other hybridization techniques, there is an
inherent level of variability associated with sample pre-
paration, sample loading, the microarrays and the detec-
tors. To address this variability it is very common to
add a “minimum difference threshold” to select out
CpG sites with little difference between two biological
conditions. Next we want to evaluate the performance
of the Beta-value and M-value statistics if we include a
minimum difference threshold in addition to the p-value
requirement.
After imposing a difference threshold, the identified
differentially methylated CpG sites will have p-values
< 0.05 and have the mean methylation level difference
between A and B samples larger than the difference
threshold. Figure 5 plots TPR and DR against the
methylation difference threshold for the Beta-value and
M-value methods. In Figure 5, at the starting point
(with thresholds of difference equal 0), there are 9533
and 9535 identified CpG sites across the entire methyla-
tion range for Beta and M-value, respectively. At the
end point (with thresholds of difference equal 0.25 and
2.0 for Beta and M-value, respectively), there are 5231
a n d5 1 6 8i d e n t i f i e dC p Gs i t e sf o rB e t aa n dM - v a l u e ,
respectively. This indicates that the threshold ranges for
Beta and M-value in Figure 5 are comparable. Figure 5
shows that TPR improves as the difference threshold
increases but the DR decreases. The performance of
Beta-value and M-value methods is very similar for the
middle analysis group (covering the approximate linear
range of logit transformation). However, the
Figure 4 Performance comparisons of Beta- and M-value in the
range of low, middle and high methylation levels based on the
relationship of 1 - Detection Rate versus True Positive Rate.
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the nonlinear (high and low) analysis groups. For the
Beta-value statistic, the TPR increases as the difference
threshold increases but DR drops dramatically. For the
M-value statistic, the TPR increases more slowly, but
DR remains high for much larger difference thresholds.
Figure 5 also provides some guidance for selecting the
difference thresholds of Beta-value and M-value statis-
tics. An ideal difference threshold would have both high
TPR and high DR, but there is a tradeoff in selecting
the threshold. From Figure 5, we can see that the TPR
gradually increases with the difference threshold before
stabilizing. Based on this, the difference threshold at the
turning point of TPR can be set as the up-limit thresh-
old because further increase of threshold will not
improve TPR very much. On the other hand, the DR is
almost constant at low thresholds and then gradually
decreases with the increasing of difference threshold. So
t h ed i f f e r e n c et h r e s h o l da tt h et u r n i n gp o i n to fD Rc a n
be set as the down-limit threshold because it can
increase the TPR without deteriorate the DR when DR
is stabilized. Based on these guidelines, we suggest the
range of threshold of M-value method should be about
between 0.4 and 1.4 (or from 1.32 to 2.64 if we convert
M-value to the non-log scale). For the Beta-value
method, because of its severe heteroscedasticity in the
Figure 5 Performance comparisons of Beta and M-value based on the True Positive Rate (TPR) and Detection Rate (DR) at different
thresholds of methylation difference. (A) TPR versus threshold of difference of Beta-value; (B) TPR versus threshold of difference of M-value;
(C) DR versus threshold of difference of Beta-value; (D) DR versus threshold of difference of M-value.
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fixed threshold. We can only suggest the threshold of
Beta-value for the middle analysis group, which is about
between 0.05 and 0.15. It should be noted that these
threshold ranges are dependent on the distribution of
intensities in the dataset so ideally these thresholds
should be determined for each dataset.
Discussion
The Beta-value method has already been widely used to
calculate methylation levels, and it is the manufacturer
recommended method for analyzing Illumina Infinium
HumanMethylation27 BeadChip microarrays. The
M-value method has been widely used in the expression
microarray analysis, and has been used to calculate
methylation levels in some methylation microarray ana-
lyses [13]. However, to date there has been no systema-
tic evaluation of the relationship between the Beta-value
and M-value methods. In this study, we demonstrate
that the two methods are related by a Logit transforma-
tion. They have an approximately linear relationship in
the middle methylation range (defined as 0.2 to 0.8 for
the Beta-value method) with a significant compression
above and below this range for the Beta-value method.
The Beta-value range is from 0 and 1 and can be inter-
preted as an approximation of the percentage of meth-
lyation. However, because the Beta-value has a bounded
range, this statistic violates the Gaussian distribution
assumption used by many statistical methods, including
the very prevalent t-test. In comparison, M-value statis-
tic can be appropriately analyzed with these methods.
To compare the performance of Beta and M-value
methods in identifying the differentially methylated CpG
sites, we designed a methylation titration experiment. As
we do not know the ‘true’ methylated CpG sites, we
have defined a set of True Positives (TPs) based on high
levels of correlation between the methylation and titra-
tion profiles. It is important to note that some true dif-
ferentially methylated CpG sites may not be included in
this set of TPs; at the same time, some false positives
may also be included in the TPs. Fortunately, athough a
small number of false positives or false negatives will
affect the estimation of TPRs and DRs, but does not
affect the overall performance comparisons between two
methods (We did simulations by randomly adding or
removing 10% TPs, and found the performance differ-
ence between Beta and M-values are consistent with the
curves shown in Figure 4. The results were not included
in the paper.). Comparing the performance based on top
ranked CpG sites (ranked based on the absolute differ-
ence between two comparing groups), the M-value
method has better detection power and a higher True
Positive Rate (TPR) in the low and high methylation
ranges due to its reduced heteroscedasticity in these
ranges. In the middle methylation range, the Beta-value
method has slightly better detection power than the
M-value method but a decreased TPR.
In microarray differential analysis, adding a difference
(or fold-change) threshold is another common practice
and effective way to improve the TPR. However, due to
the severe heteroscedasticity of the Beta-value method
outside the middle methylation ranges, it is impossible
to impose a constant difference threshold across entire
methylation range for the Beta-value method. If a con-
stant difference threshold is used for the Beta-value
method, then the detection rate outside the middle
methylation range is severely deteriorated. To solve this
problem, Illumina proposed a customized model to
detect differentially methylated CpG sites [21]. Basically,
the model fits a parabola to the standard deviation as a
function of Beta-value. However, this is inconvenient to
implement, and the fitted parameters suggested by Illu-
mina may change across different experiments under
different conditions. Performing the same set of analyses
using the M-value method demonstrates that using a
constant difference threshold is appropriate and far
easier to implement. Based on the comparison graphed
in Figure 5 we suggest setting a threshold for the
M-value method between 0.4 and 1.4 (or from 1.32 to
2.64 in the non-log scale).
Conclusions
The Beta-value method has a direct biological interpre-
tation - it corresponds roughly to the percentage of a
site that is methylated. This makes the Beta-value very
attractive when modeling the underlying biological
effect. However, this interpretation is an approximation
[22], especially when the data has not been properly
preprocessed and normalized. From an analytical and
statistical standpoint, the Beta-value method has severe
heteroscedasticity outside the middle methylation range,
which imposes serious challenges in applying many sta-
tistic models. In comparison, the M-value method is
more statistically valid in differential and other statistic
analysis as it is approximately homoscedastic.A l t h o u g h
the M-value statistic does not have an intuitive biologi-
cal meaning, it is possible to provide an accurate estima-
tion of methylation status by modeling the distribution
of the M-value statistic. In differential methylation ana-
lysis, we recommend using M-value because we can
directly apply most statistical analysis methods designed
for expression microarrays and it is easy to implement a
difference threshold adjustment to improve the TPR.
And the difference of M-value can be interpreted as the
fold-change in the non-log scale. Although both Beta-
value and M-value methods have some limitations, the
two statistics are inter-convertible using Equation 3,
enabling the use of the most appropriate method. We
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methylation analysis and also including the Beta-value
statistic in final reports due to its intuitive biological
interpretation.
Methods
Titration Samples
Similar to the titration design using Goldengate methyla-
tion chips by Bibikova and et al [12], we selected two sam-
ples with known methylation differences. Sample A is NA
10923 from Coriell Institute for Medical Research. It is a B-
Lymphocyte sample from a male donor. Sample B is HTB-
38 cell line from ATCC (http://www.atcc.org). It is a colon
cancer sample from a female donor. Sample A and B were
normalized into the same concentration, and then mixed in
five different titration ratios. Table 1 shows the detailed
information. The numbers in the row 2 and 3 in Table 1
are the percentage of sample A and B in the titration sam-
ple. Row 4 is the number of replicates of each sample.
DNA Methylation Profiling using Illumina Infinium
BeadChip Microarrays
The DNA samples were prepared following the guide-
lines suggested by the manufacturer (Illumina, Inc.), and
then measured by Illumina Infinium HumanMethyla-
tion27 BeadChip, which measures 27578 CpG sites. The
HumanMethylation27 BeadChip contains a pair of
methylated and unmethylated probes designed for each
CpG site. All experiments were conducted following the
manufacturer’s protocols by the Genomics Core at
Northwestern University. The Illumina BeadChips were
scanned with an Illumina BeadArray Reader and then
preprocessed by the Illumina GenomeStudio software.
Raw data have been deposited in the NCBI GEO data-
base under the accession number of GSE23789.
We used the Bioconductor methylumi package [23] to
input the methylation files outputted by Illumina Geno-
meStudio software and processed the methylation data
using Bioconductor lumi package [24]. The methylation
data was first passed QC and color balance check, and
then background corrected and scaled based on the
mean of all probes (using methylation simple scaling
normalization (SSN) implemented in the lumi package).
Beta-value and M-value statistics were calculated based
on Equation 1 and 2. The related preprocessing func-
tions are included in the Bioconductor lumi package
(version > 2.0) [24]. As a prefiltering step, 82 CpG sites
with more than 50% of samples having detection
p-values worse than 0.0001 were filtered before the ana-
lysis. The Pearson correlation method was used to
calculate the correlation between the titration and
methylation profiles. Welch’s t-test was used to identify
the differentially methylated CpG sites.
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